Global Health: A Look Ahead at Trends in Seven Key Areas
Client Alert | 1 min read | 04.07.22
Crowell & Moring International (CMI) commemorates “World Health Day” with the publication of our compiled health policy forecast for the year. “Global Health: A Look Ahead at Trends in Seven Key Areas” explores global health trends and challenges at the forefront of business, government and public concerns.
This forecast provides a concise outlook on key issues affecting health in 2022 and beyond. Each is an area where CMI works with our partners to make a meaningful difference. Each is an area that merits attention and concerted action to improve health. We offer our perspectives on:
- Vaccines
- Health Financing
- Antimicrobial Resistance (AMR)
- Oncology/Cervical Cancer
- Women’s Health
- Rare Diseases
- AI/Digital Health
Based in Washington, DC and Singapore, C&M International has a commitment to advancing health through our work with clients to help shape policy, regulatory, and commercial landscapes around the global. For more information on C&M International and its capabilities, please visit cmintl.com.
Contacts
Insights
Client Alert | 8 min read | 04.17.26
CMS Finalizes CY 2027 Medicare Advantage and Part D Rule: Key Implications for Plan Sponsors
On April 6, 2026, the Centers for Medicare & Medicaid Services (CMS) published its final rule governing the Medicare Advantage (Part C) and Prescription Drug Benefit (Part D) programs for Contract Year (CY) 2027. The final rule is effective June 1, 2026, with most provisions applicable to coverage beginning January 1, 2027, and marketing and communications changes taking effect October 1, 2026. Beyond payment, the rule pursues a broad deregulatory agenda aligned with Executive Order 14192, reversing marketing and enrollment safeguards introduced in 2023 and easing documentation and reporting obligations, while introducing new program integrity requirements.
Client Alert | 1 min read | 04.17.26
Client Alert | 3 min read | 04.17.26
Client Alert | 2 min read | 04.16.26
